BioHealth News Archive
These Five Capital Region Biotechs Are The Fastest Growing in America · BioBuzz
In its 24th year, the Deloitte Technology Fast 500 is the premier technology awards program in North America. The program celebrates the innovation, entrepreneurship…
Read More
Cancer researchers in Australia develop universal blood test
Australian scientists have developed a simple blood test that they claim can diagnose cancer in mere minutes by identifying a unique DNA signature present…
Read More
Institute of Human Virology researchers discover that a bacterial protein promotes cancer – EurekAlert! Science News
The Institute of Human Virology (IHV) at the University of Maryland School of Medicine (UMSOM) announced today the discovery that DnaK, a protein of…
Read More
Join us December 13, 2018 for PATHFINDER INNOVATION PROGRAM
Explore Legal Issues for Early Stage Companies Business formation and governance • Advisory Board vs. Board of Directors Equity incentive plans • NDA’s (w/…
Read More
Creatv MicroTech Receives Japanese Patent for Cancer Screening
Creatv MicroTech, Inc. (Creatv) has received notice from the Japanese Patent Office that its patent covering numerous clinical applications for the detection of cancer…
Read More
FDA chooses 8 medtech companies for opioid crisis challenge – MassDevice
The FDA has selected eight medtech companies to develop devices to help reduce the country’s opioid abuse crisis.
Read More
Rooster Bio and Paragon Biosolutions Recognized as Champions of Manufacturing
On November 29, 2018 at Martin’s West, RMI’s 2018 Champions of Maryland Manufacturing Awards ceremony drew over 600 stakeholders from around the State. The…
Read More
RoosterBio Submits U.S. FDA Master Files for CliniControl™ Line of Human Mesenchymal Stem/Stromal Cell Products
RoosterBio Inc, a leading supplier of human Mesenchymal Stem/Stromal Cell (hMSC) working cell banks and hMSC-specific bioprocess systems, announces today it has submitted a…
Read More
NEA completes secondary sale of 26 portfolio companies for about $1 bln – PE Hub
New Enterprise Associates has completed a roughly $1 billion secondary sale of 26 portfolio companies in a deal designed to bring early liquidity to…
Read More
The Untold CRISPR Story
The recent shocking reports about a human genome editing experiment have led to increased murmurings about the potential pitfalls of improved access to molecular…
Read More
BIO CEO Greenwood talks drug pricing politics after the midterms – STAT
BIO CEO Jim Greenwood won’t admit last month’s midterm elections spell trouble for the drug industry. {iframe}https://www.statnews.com/2018/12/03/the-new-congress-is-already-threatening-to-push-forward-on-drug-pricing-but-bio-ceo-jim-greenwood-isnt-changing-tack/{/iframe}
Read More
Despite CRISPR baby controversy, Harvard University will begin gene-editing sperm – MIT Technology Review
In the wild uproar around an experiment in China that claimed to have created twin girls whose genes were altered to protect them from…
Read More
Global biotech rankings – Measuring biotech innovation in 50+ countries
Why measure global biotechnology? The scope of biotechnology is broad and impacts economies, policies, and people globally. Applications range from advanced medicines to and…
Read More
Johnson & Johnson Innovation – Quick Pitch – JNJ Innovation
At Johnson & Johnson, we believe a good idea can come from anywhere. Our aim is to identify, empower and enable the best ideas…
Read More
Time is running out to register for SoPE National Chapter: Telemedicine: Leveraging Technology to Change the Face of Healthcare…Are you In or Out?
The use of tele-medicine is no longer a far off, futuristic concept. It is presently being used in many medical disciplines and in institutions…
Read More